astrina
Company flagged

Novel Laboratories, Inc. d.b.a LUPIN

Company reviews

Type Company Card addedAugust 10 Threat lists flagged Reviews1
Write a review Write a full review Share this Report the listing
people’s rating
—
nobody has rated it yet. Yours will be the first.
5 0 4 0 3 0 2 0 1 0
Astrina AI 3.0

Counted separately and kept out of the people’s average — otherwise one machine score would read as the readers’ opinion.

Threat lists · flagged Product safety recall

Official safety regulators published alerts about a product of this kind.

The record is filed under the name, not under a barcode or a company number: it describes things of this kind, not necessarily the one in front of you.

Alerts on record1 HazardFailed Stability Specification; Out of specification for Osmolarity First alertJuly 29, 2021 Latest alertJuly 29, 2021 On our lists sinceAugust 10, 2026

What to do: Check the maker, the batch and the date of the exact item you have — the alert is about this kind of product.

Where this came from: openFDA recall enforcement (drug) — An official government safety register — product recalls and safety alerts.

Open the source and search there →

Is this your listing? Sign in to claim it and reply to reviews.

Reviews · 1

Newest first Helpful With a rating
Astrina Astrina AI Astrina AI rating 2026-09-17
Novel Laboratories, Inc. d.b.a LUPIN is the kind of name that points to a pharmaceutical manufacturer with a fairly corporate face, not a consumer brand. By our assessment, it fits the sort of company people know through labels, prescriptions, and contract manufacturing rather than through a public personality. That usually means competence in formulation, compliance, and scale matter more than charm. The trade-off is that this kind of business is hard to judge from the outside, because the products are often the real story and the company name stays in the background. In practice, such firms tend to feel more administrative than glossy: lots of standards, paperwork, and manufacturing discipline. Compared with a consumer-facing health brand, it is less about selling an image and more about keeping medicines moving through a regulated chain. The right audience is anyone looking at the company as a supplier or manufacturer; it is not the sort of name that says much to a casual buyer.
Report

What is wrong with this review? A moderator reads every report.

We do not tell the author who reported them.
No live reviews here yet The first review from an account gets the green tick and sets the average for this listing. Write the first one
Have more to say? A full review with photos, video and YouTube clips — a separate page of your own. Write a full review
Write a review

Optional. With it your review counts towards that exact location, not the chain as a whole.

Guest reviews are published after moderation. Sign in to publish instantly.

What this page answers